Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan).
Authors not listed
Pfizer · 2008
Abstract
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2008). Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan). <em>Pfizer</em>. https://clinicaltrials.gov/study/NCT00845273
Vancouver
Anonymous. Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan). Pfizer. 2008.
BibTeX
@misc{anon2008Specia,
title = {Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan).},
author = {Anonymous},
journal = {Pfizer},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuroscience & Biobehavioral Reviews 2015
Preprint · OA
How fast and how often: The pharmacokinetics of drug use are decisive in addiction
JNCI Journal of the National Cancer Institute 2024
Open access · CC0
Time-restricted eating and cancer: lessons learned and considerations for a path forward
Springer eBooks 2018
Citation only
Inhibition of mTOR Signalling: A Potential Anti-aging Drug Strategy
BMC Public Health 2012
Open access · CC-BY
Trend in eating habits among Lithuanian school-aged children in context of social inequality: three cross-sectional surveys 2002, 2006 and 2010
Pediatric Nephrology 2009
Citation only
Overview of the FGF23-Klotho axis
Ageing Research Reviews 2016
Preprint · CC-BY